Clinical trial
Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus…
NCT00041626 · Introgen Therapeutics, Industry · Unknown status
Key facts
| NCT number | NCT00041626 |
|---|---|
| Title | Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone |
| Lead sponsor | Introgen Therapeutics, Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Carcinoma, Squamous Cell |
| Intervention type | Genetic |
| Interventions | INGN 201 |
| First posted | Jul 12, 2002 |
| Last update posted | Sep 11, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 10–99 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: